Table 3 Leukemia and lymphoma reporting rates in the PMD and incidence rates in SEER
0 to 11 years | 12 to 17 years | 18 to 30 years | ||||
|---|---|---|---|---|---|---|
n | Ratea | n | Ratea | n | Ratea | |
Leukemia | ||||||
PMD | 3 | 12.1 | 0 | 0 | 5 | 3.0 |
SEER | 5.4 | 3.2 | 2.6 | |||
Lymphocytic leukemia Leukemia | ||||||
PMD | 2 | 8.1 | 0 | 0 | 2 | 1.2 |
SEER | 4.4 | 2.1 | 0.9 | |||
Myeloid leukemia | ||||||
PMD | 0 | 0 | 0 | 0 | 3 | 1.8 |
SEER | 0.9 | 1.0 | 1.5 | |||
Leukemia not otherwise specified | ||||||
PMD | 1 | 4.0 | 0 | 0 | 0 | 0 |
Lymphoid neoplasm | ||||||
PMD | 3 | 12.1 | 5 | 13.1 | 15 | 8.9 |
SEER | 5.5 | 5.7 | 8.0 | |||
Hodgkin lymphoma | ||||||
PMD | 3 | 12.1 | 3 | 7.9 | 3 | 1.8 |
SEER | 0.4 | 2.0 | 4.2 | |||
Non-Hodgkin lymphoma | ||||||
PMD | 0 | 0 | 1 | 2.6 | 6 | 3.6 |
SEER | 5.2 | 3.6 | 3.7 | |||
Lymphoid not otherwise specified | ||||||
PMD | 0 | 0 | 1 | 2.6 | 6 | 3.6 |